Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: MELANOMA - RADIOTHERAPY , . Treffer: 11
2016
Partl, R; Fastner, G; Kaiser, J; Kronhuber, E; Cetin-Strohmer, K; Steffal, C; Böhmer-Breitfelder, B; Mayer, J; Avian, A; Berghold, A
KPS/LDH index: a simple tool for identifying patients with metastatic melanoma who are unlikely to benefit from palliative whole brain radiotherapy.
Support Care Cancer. 2016; 24(2):523-528
Doi: 10.1007/s00520-015-2793-7
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2015
Tarmann, L; Wackernagel, W; Avian, A; Mayer, C; Schneider, M; Winkler, P; Langmann, G
Ruthenium-106 plaque brachytherapy for uveal melanoma.
Br J Ophthalmol. 2015; 99(12):1644-1649
Doi: 10.1136/bjophthalmol-2015-306666
Web of Science
PubMed
FullText
FullText_MUG
2014
Tarmann, L; Langmann, G; Mayer, C; Weger, M; Haas, A; Wackernagel, W
Ozurdex(®) reduces the retinal thickness in radiation maculopathy refractory to bevacizumab.
Acta Ophthalmol. 2014; 92(8):e694-e696
Doi: 10.1111/aos.12424
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2013
Partl, R; Richtig, E; Avian, A; Berghold, A; Kapp, KS
Karnofsky performance status and lactate dehydrogenase predict the benefit of palliative whole-brain irradiation in patients with advanced intra- and extracranial metastases from malignant melanoma.
Int J Radiat Oncol Biol Phys. 2013; 85(3):662-666
Doi: 10.1016/j.ijrobp.2012.06.009
Web of Science
PubMed
FullText
FullText_MUG
2007
Mossböck, G; Rauscher, T; Winkler, P; Kapp, KS; Langmann, G
Impact of dose rate on clinical course in uveal melanoma after brachytherapy with ruthenium-106.
Strahlenther Onkol. 2007; 183(10):571-575
Doi: 10.1007/s00066-007-1734-x
Web of Science
PubMed
FullText
FullText_MUG
2004
Langmann, G; Wackernagel, W; Stücklschweiger, G; Feichtinger, K; Papaefthymiou, G; Faulborn, J
Dose-volume histogram regression analysis of uveal melanomas after single fraction gamma knife radiosurgery].
Ophthalmologe. 2004; 101(11):1111-1119
Doi: 10.1007/s00347-003-0984-y
Web of Science
PubMed
FullText
FullText_MUG
2003
Wolf, IH; Smolle, J; Binder, B; Cerroni, L; Richtig, E; Kerl, H
Topical imiquimod in the treatment of metastatic melanoma to skin.
Arch Dermatol. 2003; 139(3):273-276
Doi: 10.1001/archderm.139.3.273
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
1998
Petru, E; Nagele, F; Czerwenka, K; Graf, AH; Lax, S; Bauer, M; Pehamberger, H; Vavra, N
Primary malignant melanoma of the vagina: long-term remission following radiation therapy.
Gynecol Oncol. 1998; 70(1):23-26
Doi: 10.1006/gyno.1998.4982
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
1997
Kopera, D; Hohenleutner, U; Stolz, W; Landthaler, M
Ex vivo quality-switched ruby laser irradiation of cutaneous melanocytic lesions: persistence of S-100-, HMB-45- and Masson-positive cells.
Dermatology. 1997; 194(4):344-350
Doi: 10.1159/000246133
Web of Science
PubMed
FullText
FullText_MUG
1995
Langmann, A; Langmann, G; Unlücerci, C; Haller, E
Motility disorders in brachytherapy of choroid melanomas with Ru106 applicators
Ophthalmologe. 1995; 92(1):76-78
PubMed
1993
Stuecklschweiger, G; Arian-Schad, KS; Kapp, DS; Handl-Zeller, L; Hackl, AG
Analysis of temperature distributions of interstitial hyperthermia using a hot water system.
Int J Radiat Oncol Biol Phys. 1993; 26(5):891-895
Doi: 10.1016/0360-3016(93)90506-q
Web of Science
PubMed
FullText
FullText_MUG